Clinical Trials Directory

Trials / Conditions / Squamous Cell Carcinoma of the Bladder

Squamous Cell Carcinoma of the Bladder

8 registered clinical trials studyying Squamous Cell Carcinoma of the Bladder — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingEnfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
NCT06041503
National Cancer Institute (NCI)Phase 2
RecruitingSacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as
NCT06161532
National Cancer Institute (NCI)Phase 2
CompletedEvaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carci
NCT03430895
Memorial Sloan Kettering Cancer CenterPhase 2
TerminatedAdjuvant Radiation for High Risk Bladder Cancer
NCT01954173
Emory UniversityN/A
TerminatedGemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cance
NCT01611662
Fox Chase Cancer CenterPhase 2
CompletedVEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium
NCT00407485
National Cancer Institute (NCI)Phase 2
TerminatedSorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
NCT00112905
National Cancer Institute (NCI)Phase 2
CompletedTrastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tra
NCT00005831
National Cancer Institute (NCI)Phase 2